Lebanon Pharmaceuticals and Healthcare Report - Q4 2014

Business Monitor International
September 10, 2014
112 Pages - SKU: BMI5325630
Countries covered: Lebanon

Lebanon Pharmaceuticals and Healthcare Report - Q4 2014

BMI View: Lebanon's pharmaceutical sector is dominated by expensive drug imports as local firms'innovation and drug output remains low. We believe a multilateral approach to promoting generic drugs,increased local production and using competition to lower prices will dramatically improve Lebanon'sprospects for foreign direct investment. However, further drug price reductions with the health minister'srecently amended pharmaceutical bill, along with the country's ongoing political crisis, will contribute tobelow-potential market growth.

Headline Expenditure Projections

Pharmaceuticals: LBP2,056.94bn (USD1.36bn) in 2013 to LBP2,231.02bn (USD1.42bn) in 2014;+8.5% in local currency and +3.9.% in US dollar terms. Forecast adjusted to suit current marketconditions.



More Prescription Drugs reports by Business Monitor International

Pharmaceuticals and Healthcare Report - Uzbekistan Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - Uzbekistan Q4 2014BMI View: We expect Uzbekistan's healthcare spending to continue outpacing the country's economicgrowth, creating opportunities for most health ...
Pharmaceuticals and Healthcare Report - United Arab Emirates Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - United Arab Emirates Q4 2014BMI View: The UAE continues to appeal to businesses thanks to its growing economy, which willincreasingly ...
Pharmaceuticals and Healthcare Report - South Africa Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - South Africa Q4 2014BMI View: South Africa's tepid economic growth, depreciating currency and current account deficit willlimit the market potential ...
Pharmaceuticals and Healthcare Report - Serbia Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - Serbia Q4 2014BMI View: In July, Serbia's National Health Insurance Fund (RFZO) cut medicine prices by around 50%through a new ...
See all reports like this >>

More Lebanon Prescription Drugs reports

Pharmaceuticals and Healthcare : Lebanon Pharmaceuticals and Healthcare Report Q3 2014 by Business Monitor International
Pharmaceuticals and Healthcare : Lebanon Pharmaceuticals and Healthcare Report Q3 2014BMI View: Lebanon benefits from a sizeable healthcare sector where the costs of health services ...
Antibiotics Market in Lebanon to 2016 by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Lebanon. The study provides essential market ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!